PGT-A Plus

• To enhance the genetic testing of IVF embryos and expand the diagnostic capabilities and clinical utility of our preimplantation genetic testing for aneuploidy (PGT-A), we have developed and validated a parallel targeted Next-Generation Sequencing (NGS) strategy using the power of SNP technology with out the need for parental samples.

• Single Nucleotide Polymorphisms (SNPs) are changes in single nucleotides distributed throughout the genome and frequently vary at the same genomic position between individuals. Most SNPs have only two different alleles.
• SNPs can be used to detect ploidy differences, DNA
  contamination and confirm genetic relatedness between
  samples in a cohort.

• This dual assessment serves as a complementary test for the detection of the chromosome abnormalities not detected with our current approach, significantly enhancing the accuracy and confidence of the PGT-A test.

What is PGT-A Plus?

• Building upon our expertise, our latest offering, PGT-A Plus, is a 4-in-1 genetic test which combines our extensively validated in-house Next Generation Sequencing (NGS) technology with an additional and validated targeted Next Generation Sequencing (NGS) strategy using the power of SNPs (Single Nucleotide Polymorphism) without the need for parental samples.
• This advanced screening solution goes beyond Smart PGT-A by incorporating additional features, including ploidy analysis (complete chromosome sets), DNA contamination detection, and confirmation of genetic relatedness between samples in a cohort, into a standard PGT-A workflow significantly increasing accuracy and confidence in selecting the optimal embryo for transfer.

PGT-A Plus

Our most advanced 4-in-1 genetic test solution

PGT – A

Our custom and validated technology that combines next-generation sequencing (NGS) with advanced algorithms and machine learning, enabling the analysis of genomic data from embryos with exceptional accuracy and reliability.

Genetic PN Check | Ploidy detection

PGT-A Plus enables the detection of both haploidy and triploidy. This crucial assessment ensures the selection of embryos with the correct chromosomal content, minimizing the risk of genetic abnormalities. PGT-A Plus also increases the number of viable euploid embryos available for transfer by detecting true 2PN (diploid) embryos from among morphologically identified 0, 1 and 2.1/3PN embryos.

Cohort check | DNA Fingerprinting

Our quality control process includes Cohort check analysis, where we employ DNA fingerprinting techniques. This ensures accurate identification, differentiation and the assurance that the tested embryo is genetically related to the others in the patient’s cohort reducing the risk of sample mix-ups due to human error.

Detection of DNA Contamination

We have implemented measures to identify and detect both external cell/DNA and maternal cell contamination increasing the accuracy and confidence of the testing process significantly reducing the risk of misdiagnosis.